Innolign Biomedical Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Innolign Biomedical General Information


Owner and operator of a biotechnology company intended to assist in therapeutic tissue regeneration. The company's biotechnology services focus on utilizing its novel microfabrication technologies and expertise in tissue engineering to develop high throughput organ-on-chip assessment platforms, enabling the pharmaceutical industry to design novel biomaterials as products for promoting therapeutic tissue regeneration.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 3160 Chestnut Street
  • Suite 200
  • Philadelphia, PA 19104
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innolign Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 12-Feb-2021 Completed Out of Business
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator 01-Dec-2013 Completed Startup
1. Grant 01-Jan-2013 $385K Completed Startup
To view Innolign Biomedical’s complete valuation and funding history, request access »

Innolign Biomedical FAQs

  • When was Innolign Biomedical founded?

    Innolign Biomedical was founded in 2013.

  • Who is the founder of Innolign Biomedical?

    Melinda Shockley Ph.D is the founder of Innolign Biomedical.

  • Where is Innolign Biomedical headquartered?

    Innolign Biomedical is headquartered in Philadelphia, PA.

  • What industry is Innolign Biomedical in?

    Innolign Biomedical’s primary industry is Biotechnology.

  • Is Innolign Biomedical a private or public company?

    Innolign Biomedical is a Private company.

  • What is Innolign Biomedical’s current revenue?

    The current revenue for Innolign Biomedical is 000000.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »